SCHEMBL24072396

SCHEMBL24072396

CNC(=O)c1ccccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 3/20 0.44
▸ NPC1 O15118 6/20 0.43
▸ RAB9A P51151 6/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ PKM P14618 2/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MLNR O43193 1/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ ABCB11 O95342 1/20 0.42
▸ ADRB2 P07550 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27135218 0.88 CYP1A2 (0.55) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL27134415 0.87 RAB9A (0.44) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL24074429 0.86 RAB9A (0.52) STAT3NPC1RAB9APOLBPKM
SCHEMBL24073682 0.86 ALDH1A1 (0.44) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL19632762 0.85 STAT3 (0.61) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL24074427 0.84 NPC1 (0.52) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL24072305 0.84 CCNE1 (0.49) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL27134430 0.84 RAB9A (0.54) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL24074140 0.84 NPC1 (0.56) STAT3NPC1RAB9AMEN1KMT2A
SCHEMBL27134428 0.84 NPC1 (0.62) STAT3NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed
WO-2021239117-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI) , INC. (CN) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885NPC1 3949/4885RAB9A 3280/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 STAT3 3224/4885NPC1 3949/4885RAB9A 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback